Complement Factor B antibody | 014III-184.108.40.206
Filter by Application:C Reset
Mouse anti Human Complement Factor B (Ba Fragment)
- Product Type
- Monoclonal Antibody
- Complement Factor B
- (Ba FRAGMENT)
|Mouse anti Human Complement Factor B (Ba Fragment) antibody, clone 014III-220.127.116.11 recognises the 30 kDa Ba fragment of 90 kDa human complement factor B, present in blood serum. C3b associates with complement factor B, inducing conformational change. This enables complement factor D to cleave the N-terminal of complement factor B (the Ba subunit), leaving the 63 kDa Bb subunit associated with C3b, forming C3 convertase. Subunit Ba inhibits lymphocyte proliferation. Conversely, subunit Bb is involved in the proliferation of preactivated B lymphocytes.
Mouse anti Human Complement Factor B (Ba Fragment) antibody, clone 014III-18.104.22.168 blocks activity of the target protein. Removal of Sodium Azide is recommended prior to use in functional assays.
- Target Species
- Product Form
- Purified IgG - liquid
- Purified IgG prepared by affinity chromatography on Protein A from ascites
- Buffer Solution
- Borate buffered saline
- Preservative Stabilisers
- 0.1% Sodium Azide (NaN3)
- Purified human complement factor b.
- Approx. Protein Concentrations
- Current, batch-specific concentration 1.1 mg/ml
- For research purposes only
- Guaranteed until date of expiry. Please see product label.
Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.
|Application Name||Verified||Min Dilution||Max Dilution|
|Immunohistology - Frozen|
- 1Cone 014III-22.214.171.124binds both the Ba fragment and the whole protein so is not suitable for all ELISA applications.
- Histology Positive Control Tissue
- Kidney from post streptococcal glomerulonephritis patients
References for Complement Factor B antibody
Zipplies, J.K. et al. (2010) Complement factor B expression profile in a spontaneous uveitis model.
Immunobiology. 215 (12): 949-55.
Loyet, K.M. et al. (2012) Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration.
Invest Ophthalmol Vis Sci. 53 (10): 6628-37.
Katschke, K.J. Jr. et al. (2018) Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy.
Sci Rep. 8 (1): 7348.
Xu, Y. et al. (2001) Structural biology of the alternative pathway convertase.
Immunol Rev. 180: 123-35.
Ponnuraj, K. et al. (2004) Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.
Mol Cell. 14 (1): 17-28.
Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"View all Anti-Human Products
Always be the first to know.
When we launch new products and resources to help you achieve more in the lab.Yes, sign me up